This inventor holds 23 USPTO granted patents and 30 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in sGC Stimulators. Top assignees: Cyclerion Therapeutics, Inc., Ironwood Pharmaceuticals, Inc., Tisento Therapeutics Inc.. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2022)
- Newton, MA (US) (2014 - 2024)
Company Filing History:
11 out of 25 
10 out of 44 
2 out of 5 Years Active: 2014-2025
Areas of Expertise:
Title: Innovations of Takashi Nakai in sGC Stimulators
Introduction
Takashi Nakai, a prominent inventor based in Newton, MA, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 21 patents. His innovative work primarily focuses on the development of soluble guanylate cyclase (sGC) stimulators, which hold potential therapeutic value in treating various diseases.
Latest Patents
Among Nakai's latest patents is a disclosure on processes and intermediates for the preparation of soluble guanylate cyclase stimulators. This patent elaborates on novel methods for manufacturing compounds of Formula I, which are essential for enhancing sGC activity. The processes outlined in the patent are designed for large-scale production, ensuring high purity and yield of stable 3-(2-pyrimidinyl)pyrazoles. Additionally, these processes are characterized by favorable reaction conditions, facilitating scalability for industrial manufacturing.
Another critical patent focuses on the stimulators of sGC, covering not just their compounds but also their pharmaceutically acceptable salts, formulations, and prodrugs. This invention is particularly important for increasing nitric oxide concentration and cyclic Guanosine Monophosphate (cGMP), which are crucial in various therapeutic applications.
Career Highlights
Throughout his career, Takashi Nakai has collaborated with esteemed companies, such as Ironwood Pharmaceuticals and Cyclerion Therapeutics. His innovative spirit and expertise have been recognized within the pharmaceutical industry, significantly impacting therapeutic advancements.
Collaborations
Nakai has worked alongside notable colleagues, including Rajesh R Iyengar and Ara Mermerian. Their collaborations have been pivotal in propelling research and development efforts aimed at creating effective pharmaceutical solutions.
Conclusion
Takashi Nakai's contributions to the field of soluble guanylate cyclase stimulators showcase the intersection of innovation and pharmaceutical research. With a solid foundation of patents and successful collaborations, Nakai continues to be a key figure in advancing medical treatments that leverage the powerful role of nitric oxide signaling. His work not only highlights his expertise as an inventor but also his commitment to improving healthcare outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile